ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 28 filers reported holding ASLAN PHARMACEUTICALS LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $457,473 | -39.9% | 1,270,758 | 0.0% | 0.17% | -30.2% |
| Q3 2022 | $761,000 | +21.0% | 1,270,758 | 0.0% | 0.24% | +2.5% |
| Q2 2022 | $629,000 | -45.0% | 1,270,758 | 0.0% | 0.24% | -37.6% |
| Q1 2022 | $1,143,000 | -19.7% | 1,270,758 | 0.0% | 0.38% | -11.9% |
| Q4 2021 | $1,423,000 | -37.1% | 1,270,758 | 0.0% | 0.43% | -40.5% |
| Q3 2021 | $2,262,000 | -53.9% | 1,270,758 | -14.6% | 0.72% | -41.0% |
| Q2 2021 | $4,912,000 | +1.2% | 1,488,508 | +2.8% | 1.22% | +24.0% |
| Q1 2021 | $4,853,000 | +90.4% | 1,448,508 | +4.0% | 0.98% | +88.7% |
| Q4 2020 | $2,549,000 | -2.6% | 1,392,654 | +1.1% | 0.52% | +0.8% |
| Q3 2020 | $2,616,000 | -5.0% | 1,376,954 | 0.0% | 0.52% | -35.6% |
| Q2 2020 | $2,754,000 | +108.5% | 1,376,954 | +6.3% | 0.80% | +81.5% |
| Q1 2020 | $1,321,000 | -36.1% | 1,294,911 | +27.2% | 0.44% | -10.0% |
| Q4 2019 | $2,066,000 | – | 1,017,971 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,017,971 | $2,066,000 | 0.49% |
| DAFNA Capital Management LLC | 117,682 | $239,000 | 0.08% |
| Temasek Holdings (Private) Ltd | 1,422,475 | $2,888,000 | 0.02% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 415,450 | $843,000 | 0.02% |
| Virtu Financial LLC | 54,386 | $110,000 | 0.01% |
| MARSHALL WACE, LLP | 96,095 | $195,000 | 0.00% |
| UBS Group AG | 150 | $0 | 0.00% |
| DEUTSCHE BANK AG\ | 2,151 | $4,000 | 0.00% |
| MORGAN STANLEY | 18,582 | $37,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 10,000 | $20,000 | 0.00% |